+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 1202883-04-2
1202883-04-2,MFCD00603023
Catalog No.:AA00HF9L

1202883-04-2 | 2-(Allyloxy)-2-methylpropan-1-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$527.00   $369.00
- +
1g
95%
in stock  
$1,239.00   $868.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00HF9L
Chemical Name:
2-(Allyloxy)-2-methylpropan-1-ol
CAS Number:
1202883-04-2
Molecular Formula:
C7H14O2
Molecular Weight:
130.1849
MDL Number:
MFCD00603023
SMILES:
CC(C)(CO)OCC=C
Properties
Computed Properties
 
Complexity:
86.9  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
0.7  

Downstream Synthesis Route

[1]Locationinpatent:experimentalpartPiergentili,Alessandro;Quaglia,Wilma;Bello,FabioDel;Giannella,Mario;Pigini,Maria;Barocelli,Elisabetta;Bertoni,Simona;Matucci,Rosanna;Nesi,Marta;Bruni,Bruno;Vaira,MassimoDi[BioorganicandMedicinalChemistry,2009,vol.17,#24,p.8174-8185]

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2011/26904,2011,A1Locationinpatent:Page/Pagecolumn60

[3]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66065,2012,A1Locationinpatent:Page/Pagecolumn79

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66070,2012,A1Locationinpatent:Page/Pagecolumn86

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101063,2012,A1Locationinpatent:Page/Pagecolumn107

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101066,2012,A1Locationinpatent:Page/Pagecolumn93

[7]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101064,2012,A1Locationinpatent:Page/Pagecolumn147

[8]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/26917,2011,A1Locationinpatent:Page/Pagecolumn61

[9]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2Locationinpatent:Page/Pagecolumn83

[1]Locationinpatent:experimentalpartPiergentili,Alessandro;Quaglia,Wilma;Bello,FabioDel;Giannella,Mario;Pigini,Maria;Barocelli,Elisabetta;Bertoni,Simona;Matucci,Rosanna;Nesi,Marta;Bruni,Bruno;Vaira,MassimoDi[BioorganicandMedicinalChemistry,2009,vol.17,#24,p.8174-8185]

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2011/26904,2011,A1Locationinpatent:Page/Pagecolumn60-61

[3]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66065,2012,A1Locationinpatent:Page/Pagecolumn79

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66070,2012,A1Locationinpatent:Page/Pagecolumn86

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101063,2012,A1Locationinpatent:Page/Pagecolumn137

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101066,2012,A1Locationinpatent:Page/Pagecolumn93-94

[7]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101064,2012,A1Locationinpatent:Page/Pagecolumn178-179

[8]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/26917,2011,A1Locationinpatent:Page/Pagecolumn61

[9]CurrentPatentAssignee:FUJIANAKEYLINKBIOTECHNOLOGY-EP3587420,2020,A1Locationinpatent:Paragraph0520-0521;0524

[10]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2Locationinpatent:Page/Pagecolumn83

[11]CurrentPatentAssignee:ECCOGENESHANGHAI-WO2021/83209,2021,A1Locationinpatent:Paragraph00294

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2Locationinpatent:Page/Pagecolumn233

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101063,2012,A1Locationinpatent:Page/Pagecolumn107

[3]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101064,2012,A1Locationinpatent:Page/Pagecolumn147-148

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2011/26904,2011,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66065,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101064,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101063,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101066,2012,A1

[3]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66070,2012,A1

[4]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/26917,2011,A1

[5]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2011/26904,2011,A1

[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66065,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101064,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101063,2012,A1CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/101066,2012,A1

[3]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66070,2012,A1

[4]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/26917,2011,A1

[5]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1202883-04-2
111-45-5

111-45-5

 6777-00-0

6777-00-0

 27274-31-3

27274-31-3

 21460-36-6

21460-36-6

 25136-53-2

25136-53-2
Building Blocks
More >
Tags:1202883-04-2 Molecular Formula|1202883-04-2 MDL|1202883-04-2 SMILES|1202883-04-2 2-(Allyloxy)-2-methylpropan-1-ol